TY - JOUR
T1 - Ensuring effective prevention of iodine deficiency disorders
AU - Völzke, Henry
AU - Caron, Philippe
AU - Dahl, Lisbeth
AU - De Castro, João J.
AU - Erlund, Iris
AU - Gaberšček, Simona
AU - Gunnarsdottir, Ingibjörg
AU - Hubalewska-Dydejczyk, Alicja
AU - Ittermann, Till
AU - Ivanova, Ludmila
AU - Karanfilski, Borislav
AU - Khattak, Rehman M.
AU - Kusić, Zvonko
AU - Laurberg, Peter
AU - Lazarus, John H.
AU - Markou, Kostas B.
AU - Moreno-Reyes, Rodrigo
AU - Nagy, Endre V.
AU - Peeters, Robin P.
AU - Pirags, Valdis
AU - Podoba, Ján
AU - Rayman, Margaret P.
AU - Rochau, Ursula
AU - Siebert, Uwe
AU - Smyth, Peter P.
AU - Thuesen, Betina H.
AU - Troen, Aron
AU - Vila, Lluís
AU - Vitti, Paolo
AU - Zamrazil, Vaclav
AU - Zimmermann, Michael B.
N1 - Publisher Copyright:
© Mary Ann Liebert, Inc. 2016.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.
AB - Background: Programs initiated to prevent iodine deficiency disorders (IDD) may not remain effective due to changes in government policies, commercial factors, and human behavior that may affect the efficacy of IDD prevention programs in unpredictable directions. Monitoring and outcome studies are needed to optimize the effectiveness of IDD prevention. Summary: Although the need for monitoring is compelling, the current reality in Europe is less than optimal. Regular and systematic monitoring surveys have only been established in a few countries, and comparability across the studies is hampered by the lack of centralized standardization procedures. In addition, data on outcomes and the cost of achieving them are needed in order to provide evidence of the beneficial effects of IDD prevention in countries with mild iodine deficiency. Conclusion: Monitoring studies can be optimized by including centralized standardization procedures that improve the comparison between studies. No study of iodine consumption can replace the direct measurement of health outcomes and the evaluation of the costs and benefits of the program. It is particularly important that health economic evaluation should be conducted in mildly iodine-deficient areas and that it should include populations from regions with different environmental, ethnic, and cultural backgrounds.
UR - http://www.scopus.com/inward/record.url?scp=84958047952&partnerID=8YFLogxK
U2 - 10.1089/thy.2015.0543
DO - 10.1089/thy.2015.0543
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 26700864
AN - SCOPUS:84958047952
SN - 1050-7256
VL - 26
SP - 189
EP - 196
JO - Thyroid
JF - Thyroid
IS - 2
ER -